| Oct 24 |
Senseonics Holdings, Inc. Schedules Third Quarter 2024 Earnings Release and Conference Call for November 7, 2024 at 4:30 P.M. Eastern Time
|
| Oct 16 |
Senseonics to Host Virtual KOL Event on Eversense 365: FDA Clearance and Commercialization Plans for the World's First One-Year CGM System
|
| Oct 10 |
Mercy Places First Commercial Eversense 365: The World's First and Only 365-Day Continuous Glucose Monitor
|
| Sep 24 |
Senseonics Stock Down Despite New FDA Approval for Eversense 365
|
| Sep 18 |
Senseonics and Ascensia announce FDA approval for one-year CGM system
|
| Sep 17 |
FDA Approves Glucose Monitor That Can Be Worn for a Year
|
| Sep 17 |
Senseonics Eversense 365 glucose monitor cleared in the U.S.
|
| Sep 17 |
Senseonics receives FDA clearance for one-year CGM
|
| Sep 17 |
Eversense 365 Receives FDA Clearance: The World’s First One Year CGM
|
| Sep 6 |
Senseonics Holdings, Inc. to Participate in the Upcoming H.C. Wainwright 26th Annual Global Investment Conference
|
